Conférences  >  Médecine & Soins de Santé  >  Cancérologie  >  France

The European Association for Cancer Research

This meeting will explore the burgeoning field of cancer persister cells, a rare subset of cells which have emerged over the last decade as a significant factor in cancer treatment failure. Unlike resistance cells, which harbour genetic alterations enabling survival despite therapy, persister cells exhibit transient drug tolerance through reversible, non-mutational mechanisms. Our conference on this topic will bring together investigators from across the world to delve into molecular mechanisms, therapeutic targets, and emerging clinical implications of cancer persister cells, fostering collaboration and community-building in this pivotal and rapidly growing area of research.

Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer persister cells, cancer resistant cells, non-genetic drug resistance, treatment response, treatment success, treatment failure, molecular mechanisms of resistance and persistence, novel study methodologies, targeting vulnerabilities within persister cells, clinical implications and applications

Pharmacologie et développement des médicaments,    Biologie moléculaire